IDEXX Laboratories Inc (NASDAQ:IDXX) over-valued by 24%
| Website | https://www.idexx.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $45,040,152,576 |
| Beta | 0.862107 |
| Average Volume | $421,201 |
| Last Dividend | 0% |
| Price on Nov 1, 2022 | $372.64 |
| Autochartist™ Valuation | $281.83 |
| Conclusion |
24% over-valued |
| Download Report |
